| human | Q5 |
| P2798 | Loop ID | 20626 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 146848918 |
| P856 | official website | http://users.path.ox.ac.uk/~scobbold/tig/spc.html |
| P496 | ORCID iD | 0000-0003-1206-4880 |
| P1153 | Scopus author ID | 7006864896 |
| P214 | VIAF ID | 306206685 |
| P108 | employer | University of Oxford | Q34433 |
| P734 | family name | Cobbold | Q30525731 |
| Cobbold | Q30525731 | ||
| Cobbold | Q30525731 | ||
| P735 | given name | Stephen | Q4927100 |
| Stephen | Q4927100 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q34726892 | "Infectious" transplantation tolerance. |
| Q33267507 | A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein |
| Q81039592 | A key role for TGF-beta signaling to T cells in the long-term acceptance of allografts |
| Q61651826 | A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigens |
| Q61651690 | A role for Th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection |
| Q39663583 | A role for regulatory T cells in acceptance of ESC-derived tissues transplanted across an major histocompatibility complex barrier |
| Q68739938 | A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants |
| Q61651768 | A theoretical framework for self-tolerance and its relevance to therapy of autoimmune disease |
| Q61651698 | AMPLIFICATION OF NATURAL REGULATORY IMMUNE MECHANISMS FOR TRANSPLANTATION TOLERANCE1 |
| Q51983574 | Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. |
| Q61651755 | Adoptive Suppression of Erythrocyte Autoantibodies in Lyt-2+Depleted Recipients |
| Q48576881 | Advantages of rat monoclonal antibodies |
| Q73207762 | Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection |
| Q35624704 | Antibody-induced transplantation tolerance: the role of dominant regulation |
| Q53859655 | Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. |
| Q35927620 | Biomarkers of transplantation tolerance: more hopeful than helpful? |
| Q61651665 | CAMPATH-1 antibodies in stem-cell transplantation |
| Q61651706 | CD 4 and CD 8 monoclonal antibody therapy in canine renal allografts |
| Q77952289 | CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts |
| Q61651715 | CD4 and CD8 monoclonal antibody therapy: Strategies to prolong renal allograft survival in the dog |
| Q61651783 | CD4 monoclonal antibody pairs for immunosuppression and tolerance induction |
| Q38063958 | CD73 and adenosine generation in the creation of regulatory microenvironments. |
| Q46317686 | CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice |
| Q61651741 | Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia |
| Q45056267 | Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression. |
| Q33241067 | Co-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning |
| Q83162534 | Combining regulation with suppression and aiming for tolerance |
| Q37773431 | Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link |
| Q42798233 | Cultured keratinocyte grafts are recognized, but not rejected by CD8+ T cells in vivo |
| Q61651670 | Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance |
| Q61651672 | DOMINANT TOLERANCE AND LINKED SUPPRESSION INDUCED BY THERAPEUTIC ANTIBODIES DO NOT DEPEND ON FAS-FASL INTERACTIONS1 |
| Q73641336 | Defective fasL reveals immunregulation after costimulation blockade |
| Q61651771 | Delay in onset of insulitis in NOD mice following a single injection of CD 4 and CD8 antibodies |
| Q52059885 | Depletion of CD4+ and CD8+ cells eliminates immunologic memory of thyroiditogenicity in murine experimental autoimmune thyroiditis. |
| Q61651758 | Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis |
| Q61651807 | Detection of monoclonal antibodies against cell surface antigens: the use of antiglobulins coupled to red blood cells |
| Q43977064 | Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system |
| Q36061019 | Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells |
| Q61651663 | Dominant transplantation tolerance impairs CD8+ T cell function but not expansion |
| Q35538145 | Dominant transplantation tolerance. Opinion |
| Q35971446 | Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells |
| Q38586130 | Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse. |
| Q36693370 | Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance |
| Q53637597 | Exploiting tolerance processes in transplantation. |
| Q53530309 | Fc-disabled anti-mouse CD40L antibodies retain efficacy in promoting transplantation tolerance. |
| Q36305999 | Foxp3 expression is required for the induction of therapeutic tissue tolerance |
| Q47644661 | Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen |
| Q61651632 | Generation of anti-inflammatory adenosine byleukocytes is regulated by TGF-β |
| Q61651628 | Guiding Postablative Lymphocyte Reconstitution as a Route Toward Transplantation Tolerance |
| Q61651673 | HIGH DOSE BONE MARROW TRANSPLANTATION INDUCES DELETION OF ANTIGEN-SPECIFIC T CELLS IN A FAS-INDEPENDENT MANNER1 |
| Q38201272 | Harnessing FOXP3+ regulatory T cells for transplantation tolerance. |
| Q56907926 | How do monoclonal antibodies induce tolerance? A role for infectious tolerance? |
| Q60062009 | Humanised monoclonal antibody therapy for rheumatoid arthritis |
| Q28510654 | IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals |
| Q34524237 | Identification of regulatory T cells in tolerated allografts |
| Q36593774 | Immune privilege induced by regulatory T cells in transplantation tolerance |
| Q61651809 | Immunohistological screening in the selection of monoclonal antibodies: the use of isotype-specific antiglobulins |
| Q79300097 | Immunomodulation of dog islets using a cocktail of monoclonal antibodies |
| Q54033319 | Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies. |
| Q55161694 | Inducing a tolerogenic microenvironment within tissues. |
| Q61651641 | Induction of Regulatory T Cells and Dominant Tolerance by Dendritic Cells Incapable of Full Activation |
| Q47644499 | Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants |
| Q55042547 | Induction of tolerance in peripheral T cells with monoclonal antibodies. |
| Q36563558 | Infectious tolerance and the long-term acceptance of transplanted tissue |
| Q37246191 | Infectious tolerance via the consumption of essential amino acids and mTOR signaling |
| Q55068093 | Infectious tolerance. |
| Q61651707 | Isolation and expression of cDNA encoding the canine CD4 and CD8α antigens |
| Q61651789 | Isolation of low-frequency class-switch variants from rat hybrid myelomás |
| Q28750209 | Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target |
| Q69891851 | Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia |
| Q33502949 | MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation |
| Q54193778 | Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. |
| Q61651775 | Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination |
| Q45753829 | Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. |
| Q35703967 | Monoclonal antibodies as agents to reinduce tolerance in autoimmunity. |
| Q72202507 | Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW) |
| Q59074162 | Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance |
| Q61651745 | Monoclonal-Antibody Therapy in Systemic Vasculitis |
| Q43507473 | Monoclonals and marrow transplants |
| Q28513895 | Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells |
| Q81120666 | New trends in immunosuppression |
| Q37273245 | Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression |
| Q34241129 | Regulating the immune response to transplants. a role for CD4+ regulatory cells? |
| Q53530470 | Regulation and privilege in transplantation tolerance. |
| Q33195020 | Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms |
| Q35703532 | Regulatory T cells and organ transplantation |
| Q43563597 | Regulatory T cells and transplantation tolerance. |
| Q35069619 | Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance |
| Q61651648 | Regulatory T cells in transplantation |
| Q31035510 | Regulatory T cells overexpress a subset of Th2 gene transcripts |
| Q47737273 | Regulatory T cells: context matters |
| Q82463679 | Rejecting Minors—It's All in the Presentation |
| Q34793904 | Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms |
| Q54356874 | Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression. |
| Q61651643 | SAGE Analysis of Cell Types Involved in Tolerance Induction |
| Q61651694 | STRAIN VARIATION IN SUSCEPTIBILITY TO MONOCLONAL ANTIBODY-INDUCED TRANSPLANTATION TOLERANCE1 |
| Q61651819 | Segregation of mouse hemopoietic progenitor cells using the monoclonal antibody, YBM/42 |
| Q35613442 | Serial analysis of gene expression provides new insights into regulatory T cells |
| Q45047397 | Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase |
| Q43913093 | Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody |
| Q35237468 | Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance |
| Q34974777 | T cell tolerance in transplantation: possibilities for therapeutic intervention. |
| Q36251293 | T cell tolerance induced by therapeutic antibodies |
| Q37916936 | TGF-β in transplantation tolerance |
| Q61651701 | TOLERANCE AND SUPPRESSION IN A PRIMED IMMUNE SYSTEM1 |
| Q53385340 | Th17 cells induce a distinct graft rejection response that does not require IL-17A. |
| Q40626052 | The immunology of companion animals: reagents and therapeutic strategies with potential veterinary and human clinical applications. |
| Q61651766 | The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies |
| Q43414853 | The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies |
| Q61651728 | The use of monoclonal antibodies to achieve immunological tolerance |
| Q40767477 | The use of monoclonal antibodies to achieve immunological tolerance. |
| Q34441123 | Therapeutic aspects of tolerance. |
| Q59057896 | Therapeutic potential of monovalent monoclonal antibodies |
| Q59082223 | Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo |
| Q28509998 | Tmem176B and Tmem176A are associated with the immature state of dendritic cells |
| Q61651732 | Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8 |
| Q69136267 | Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1) |
| Q51572910 | Tolerogenicity is not an absolute property of a dendritic cell. |
| Q42428575 | Translating Tolerogenic Therapies to the Clinic - Where Do We Stand and What are the Barriers? |
| Q40573339 | What can be done to prevent graft versus host disease? |
| Q37787584 | mTOR signalling and metabolic regulation of T cell differentiation |
Search more.